NFKB1 and neoplasm: Chemotherapy with cisplatin, daunomycin, doxorubicin, 5-fluorouracil, paclitaxel, tamoxifen, vinblastine, and vincristine may cause chemoresistance by activating the NF-κB, and NF-κB inhibition acts as radiosensitizer of the tumor cells (Silva et al., 2018).